Market Tracker

10/31 7:05pm ET

Clovis Oncology Inc (NASDAQ:CLVS)

59.66
Data as of Oct 31
 +0.50 / +0.85%
Today’s Change
35.33
Today|||52-Week Range
93.33
-1.01%
Year-to-Date

Today’s Trading

Previous close59.16
Today’s open60.03
Day’s range59.11 - 62.20
Volume828,432
Average volume (3 months)802,168
Market cap$2.0B
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+0.67%
Earnings growth (this year)-35.44%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.03

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.35+1.22%
LCILannett Company Inc+0.83+1.49%
IRWDIronwood Pharmaceuti...-0.15-1.06%
THRXTheravance Inc-0.19-1.17%
Data as of 4:04pm ET, 10/31/2014

Financials

Last reporting dateOctober 30, 2014
EPS forecast (this quarter)-$1.01
Annual revenue (last year)$0.00
Annual profit (last year)-$84.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
Chief Financial Officer, Secretary &
Executive VP
Erle T. Mast
Corporate headquarters
Boulder, Colorado

Forecasts